BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 27, 2024
See today's BioWorld
Home
» In the clinic for Sept. 13, 2023
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
In the clinic for Sept. 13, 2023
Sep. 13, 2023
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Acelyrin, Aerami, Aim, Algo, Altimmune, Anokion, Artiva, Arrowhead, Astrazeneca, Avalyn, Curevac, Day One, Dianthus, Foresee, GSK, Humacyte, Hutchmed, IO Biotech, Lisata, Lyra, Mindmed, Myeloid, Neurocrine, Nextcure, Nuvectis, Ose, Replicate, RS Oncology, Sorrento, Sparrow, Valbiotis, Vistagen.
BioWorld
Briefs
In the clinic
Coronavirus